Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
Study Phase: phase 1 and phase 2
Objective: Evaluation of the effect of lenalidomide, cyclophophamide and prednisone (REP) in
patients with relapsed multiple myeloma previously treated with lenalidomide
Study design: prospective, multicenter, non-randomized